Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
最新の財務諸表(Form-10K)によると、Becton Dickinson and Coの総資産は$0で、純損失は$0です。
BDXの主要な財務比率は何ですか?
Becton Dickinson and Coの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Becton Dickinson and Coの収益はセグメントまたは地域別にどのように分けられていますか?
Becton Dickinson and Co の最大収益セグメントは Medication Delivery Solutions で、最新の利益発表における収益は 4,575,000,000 です。地域別に見ると、United States が Becton Dickinson and Co の主要市場であり、収益は 12,790,000,000 です。